Evidence map›Paper›PMID 35085528›Full record

ReviewThe American journal of the medical sciences2022

A Historical Perspective of Healthcare Disparity and Infectious Disease in the Native American Population.

Jamie E Ehrenpreis, Eli D Ehrenpreis

Open access · greenAbstract readReview
In one paragraph

Review in The American journal of the medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Antiviral activity of nitazoxanide againstJournal of virus eradication · 2023
    Article
  14. Article
  15. The Many Hosts of Mycobacteria 9 (MHM9): A conference report.Tuberculosis (Edinburgh, Scotland) · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jamie E EhrenpreisAHS Family Health Center, Skokie, IL, USA.
Eli D EhrenpreisAdvocate Lutheran General Hospital, Park Ridge, IL, USA; E2Bio Life Sciences, Evanston, IL, USA. Electronic address: Eli.Ehrenpreis@aah.org.
Advocate Lutheran General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence and severity of COVID-19 infections have been disproportionately high in Native American populations. Native Americans are a high-risk group for COVID-19 because of a variety of healthcare disparities. Historically, these populations suffered excessively during previous epidemics in the United States (US). Several epidemics occurred when disease-naïve indigenous peoples were exposed to European settlers with herd immunity. Native American populations had four times higher mortality in the 1918 Spanish flu epidemic. Deaths from H1N1 infections were higher in Native Americans and most cases and deaths from the Hantavirus pulmonary syndrome (HPS) occurred in Native Americans. Other infectious diseases, including HIV, hepatitis A and hepatitis C are more also common. Diabetes, alcoholism and cardiovascular diseases, all risk factors for severity and mortality in COVID-19 infection, are also more common in this group. Addressing the root causes of enhanced risk in Native American populations will improve outcomes from COVID-19 and future pandemics.

Indexed as

Communicable DiseasesCOVID-19Influenza A Virus, H1N1 SubtypeInfluenza Pandemic, 1918-1919American Indian or Alaska NativeHealthcare DisparitiesHumansPandemicsSARS-CoV-2United StatesAlcoholismCoronavirusCOVID-19EpidemicEpidemiologyHantavirusHealthcare disparitiesHepatitis AHIVMedical HistoryNative AmericanPandemic, Small poxPovertySanitationSARS-CoV-2Tuberculosis

Identifiers

PMID35085528
PMCPMC8785365
OpenAlexW4206971192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.